BIOMAT Database Logo BIOMAT Database Logo

[Eye changes in hyperlipoproteinaemia type II (author's transl)]. 1977

K Majewska, and M Ciswicka-Sznajdermanowa, and K Czechowicz-Janicka

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005128 Eye Diseases Diseases affecting the eye. Eye Disorders,Eye Disease,Eye Disorder
D005141 Eyelid Diseases Diseases involving the EYELIDS. Disease, Eyelid,Diseases, Eyelid,Eyelid Disease
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006937 Hypercholesterolemia A condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population. Hypercholesteremia,Elevated Cholesterol,High Cholesterol Levels,Cholesterol Level, High,Cholesterol Levels, High,Cholesterol, Elevated,Cholesterols, Elevated,Elevated Cholesterols,High Cholesterol Level,Hypercholesteremias,Hypercholesterolemias,Level, High Cholesterol,Levels, High Cholesterol
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

K Majewska, and M Ciswicka-Sznajdermanowa, and K Czechowicz-Janicka
[Type II hyperlipoproteinaemia treated with etiroxate (author's transl)].
October 1979, Casopis lekaru ceskych,
K Majewska, and M Ciswicka-Sznajdermanowa, and K Czechowicz-Janicka
[Type II familial hyperlipoproteinaemia : value of plasma exchange treatment (author's transl)].
January 1982, Annales de medecine interne,
K Majewska, and M Ciswicka-Sznajdermanowa, and K Czechowicz-Janicka
[On the treatment of hyperlipoproteinaemia type II with cholestyramine (author's transl)].
December 1973, Casopis lekaru ceskych,
K Majewska, and M Ciswicka-Sznajdermanowa, and K Czechowicz-Janicka
[Generalized ceroid histiocytosis in type 5 hyperlipoproteinaemia (author's transl)].
November 1979, Wiener klinische Wochenschrift,
K Majewska, and M Ciswicka-Sznajdermanowa, and K Czechowicz-Janicka
[Xantinol-nicotinate in primary type-V hyperlipoproteinaemia (author's transl)].
September 1976, Deutsche medizinische Wochenschrift (1946),
K Majewska, and M Ciswicka-Sznajdermanowa, and K Czechowicz-Janicka
[A case of hyperlipoproteinaemia of type I (author's transl)].
May 1979, Klinische Padiatrie,
K Majewska, and M Ciswicka-Sznajdermanowa, and K Czechowicz-Janicka
Type II hyperlipoproteinaemia.
March 1973, Clinics in endocrinology and metabolism,
K Majewska, and M Ciswicka-Sznajdermanowa, and K Czechowicz-Janicka
[Serum lipid changes in familial hyperlipoproteinaemia during spa treatment (author's transl].
September 1981, Casopis lekaru ceskych,
K Majewska, and M Ciswicka-Sznajdermanowa, and K Czechowicz-Janicka
[Etiroxate treatment for hyperlipoproteinaemia type IIa and IIb (author's transl)].
May 1982, Casopis lekaru ceskych,
K Majewska, and M Ciswicka-Sznajdermanowa, and K Czechowicz-Janicka
[Effect of colestipol on plasma lipids in patients affected by type Ii primary hyperlipoproteinaemia (author's transl)].
January 1980, Therapie,
Copied contents to your clipboard!